American Pharmaceutical News In Review

View online

Forward to a friend | Facebook | Twitter

April 22, 2021

Newsletter Sponsor

Webinar: Quantifying Residual Host Cell DNA – Register Today!

The HEK293 cell line is one of the most widely used in the production and manufacturing of various biologics, from recombinant proteins to viral vectors. It is critical that residual host cell DNA is minimized in the final drug substance to ensure product quality and patient safety.

	Industry News

Pacira BioSciences Announces Investment in Spine BioPharma
Supports clinical advancement of lead candidate, Remedisc, for degenerative disc disease. read more »

GW Pharmaceuticals Receives European Commission Approval for EPIDYOLEX® (cannabidiol) for the Treatment of Seizures Associated with Tuberous Sclerosis Complex
GW Pharmaceuticals announces that the EC has approved the Type II variation application for ... read more »

Over-the-Counter COVID-19 Testing Now Available at CVS Pharmacy
CVS Pharmacy announces the availability of three over-the-counter COVID-19 testing options in stores... read more »

	Infographic

Measuring Total Organic Carbon (TOC) Continuously in Real-Time
Total Organic Carbon (TOC) control is essential in the production of high purity pharmaceutical water. Whether you are upgrading your current system ... read more »

	Featured Articles

Recommendations for High Parameter Flow Cytometry Assay Development to Understand Cell Therapy Products: Considerations for CAR-T Therapy Flow Cytometry Based Analytical Assays Research in cell therapies has grown in the past few years with the FDA approval of Yescarta (axicabtagene ciloleucel) in 2017 for relapsed or ... read more »

Bacterial Endotoxins Testing of Water-Insoluble Drug Substances by Means of Dispersion with Dimethyl Sulfoxide Active pharmaceutical ingredients are often poorly soluble in water. The detection of bacterial endotoxins in such substances requires a ... read more »

	Featured Video

On-Demand Webinar: Risk Assessment for Potential Elemental Impurities on Drug Products/Medical Devices
This webinar will address how to deal with “Risk Assessment for Potential Elemental Impurities” on Drug Products and Medical Devices. The USP, in ... watch »

This information is being brought to you because you are a subscriber to
American Pharmaceutical Review. To ensure delivery to your inbox,
please add newsletters@americanpharmaceuticalreview.com to your address book.

Manage your Subscription | Unsubscribe | Contact American Pharmaceutical Review

American Pharmaceutical Review
164 Townsend St. Unit 2
San Francisco, CA 94107 USA